Noticias y vídeos - ADL BIONATUR

DGAP-News: ADL Bionatur Solutions / Key word(s): Agreement ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million 02.12.2019 / 09:06 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS WINS NEW FERMENTATION CLIENT WITH CONTRACT REVENUES OF EUR 20 MILLION The agreement with a leading Swiss biotech company includes technology transfer, upscaling and industrial-scale production of high value-added innovative ingredients...

DGAP-News: ADL Bionatur Solutions / Key word(s): 9 Month figures ADL Bionatur Solutions Reports Continued Strong Revenue Growth for Third Quarter 14.11.2019 / 09:30 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS REPORTS CONTINUED STRONG REVENUE GROWTH FOR THIRD QUARTER Third quarter 2019 revenues more than double to EUR 12.5 million Adjusted EBITDA for the third quarter continues strong upward trajectory amounting to EUR 1.6 million On track to...

DGAP-News: ADL Bionatur Solutions / Key word(s): Half Year Results Financial results for the first half of 2019: ADL Bionatur Solutions increases revenues by 138% and confirms positive operating results 10.10.2019 / 11:14 The issuer is solely responsible for the content of this announcement. FINANCIAL RESULTS FOR THE FIRST HALF OF 2019: ADL BIONATUR SOLUTIONS INCREASES REVENUES BY 138% AND CONFIRMS POSITIVE OPERATING RESULTS Revenues of the first half of 2019 grew to EUR 22.5 million reflecting...

DGAP-News: ADL Bionatur Solutions / Key word(s): Financing ADL BIONATUR SOLUTIONS REINFORCES ITS GROWTH STRATEGY WITH A EUR 25 MILLION DEBT FINANCING FROM KARTESIA 12.08.2019 / 09:00 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS REINFORCES ITS GROWTH STRATEGY WITH A EUR 25 MILLION DEBT FINANCING FROM KARTESIA - Proceeds complete the necessary investments to execute ADL's strategic business plan for the next four years, strengthening its CMO...

DGAP-News: ADL Bionatur Solutions / Key word(s): Alliance ADL BIONATUR SOLUTIONS ENTERS INTO AN INITIAL EUR 13 MILLION STRATEGIC ALLIANCE WITH JAPANESE PHARMA COMPANY 07.08.2019 / 09:15 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS ENTERS INTO AN INITIAL EUR 13 MILLION STRATEGIC ALLIANCE WITH JAPANESE PHARMA COMPANY - Alliance reaffirms ADL as global supply partner of sterile active pharmaceutical ingredients - Revenues of initial EUR 13 Million...

DGAP-News: ADL Bionatur Solutions / Key word(s): Contract ADL Bionatur Solutions and Amyris Expand Contract to 2020 22.07.2019 / 08:45 The issuer is solely responsible for the content of this announcement. ADL Bionatur Solutions and Amyris Expand Contract to 2020 Contract expanded to 2020 with ADL revenues anticipated to exceed EUR 12 million Renewal confirms Amyris's strong product growth across the company's product lines and reaffirms its leadership as a disruptive company creating products...

ADL Bionatur Solutions and Amyris Expand Contract to 2020 - Contract expanded to 2020 with ADL revenues anticipated to exceed EUR 12 million - Renewal confirms Amyris's strong product growth across the company's product lines and reaffirms its leadership as a disruptive company creating products that support clean, best-in-class performance and sustainable production for a growing world - Expansion confirms ADL's leading position in fermentation production in Southern Europe PR Newswire LEÓN,...

DGAP-News: ADL Bionatur Solutions / Key word(s): Contract ADL Bionatur Solutions Increases 2019 Production for a Global Nutrition Company for Additional Revenues of over EUR 2.5 Million 09.07.2019 / 10:31 The issuer is solely responsible for the content of this announcement. ADL Bionatur Solutions Increases 2019 Production for a Global Nutrition Company for Additional Revenues of over EUR 2.5 Million - Increase of the production by 75% in the last quarter of 2019 - Long-standing fermentation...

DGAP-News: ADL Bionatur Solutions / Key word(s): Quarter Results ADL Bionatur Solutions reports strong financial results for the first quarter of 2019 07.05.2019 / 17:46 The issuer is solely responsible for the content of this announcement. ADL BIONATUR SOLUTIONS REPORTS STRONG FINANCIAL RESULTS FOR THE FIRST QUARTER OF 2019 Q1 revenues grow by 134% to EUR 10.0 million Q1 EBITDA of EUR 114 thousand marks entering profitability Strong guidance for financial year 2019: EUR 50-55 million revenues...

DGAP-News: ADL Bionatur Solutions / Key word(s): Research Update Banco Sabadell gives ADL Bionatur Solutions an upside potential of 78% 06.05.2019 / 13:34 The issuer is solely responsible for the content of this announcement. BANCO SABADELL GIVES ADL BIONATUR SOLUTIONS AN UPSIDE POTENTIAL OF 78% - Sales estimated to double in 2019 and exceed EUR 50 million - The analysts expect ADL to achieve positive EBITDA and positive net profit for the full year in 2019 - Valuation range of between EUR 2.5...

DGAP-News: ADL Bionatur Solutions / Key word(s): Alliance Nutricion Center NC and ADL Bionatur Solutions sign a strategic alliance to tackle weight control by rebalancing the gut microbiome 19.02.2019 / 11:31 The issuer is solely responsible for the content of this announcement. Nutricion Center NC and ADL Bionatur Solutions sign a strategic alliance to tackle weight control by rebalancing the gut microbiome - First age-specific products for weight control by addressing the gastrointestinal...

DGAP-News: ADL Bionatur Solutions / Key word(s): Research Update Analyst coverage of ADL Bionatur Solutions initiated by Checkpoint with a target price of EUR 3.20 per share 12.02.2019 / 13:45 The issuer is solely responsible for the content of this announcement. ANALYST COVERAGE OF ADL BIONATUR SOLUTIONS INITIATED BY CHECKPOINT WITH A TARGET PRICE OF EUR 3.20 PER SHARE - Potential 12-month upside of 51% relative to current share price of EUR 2.12 - Estimated enterprise value of EUR 160 million...

DGAP-News: ADL Bionatur Solutions / Key word(s): Research Update Edison initiates coverage of ADL Bionatur Solutions forecasting an equity valuation of EUR 2.37 per share with an upside potential of 42% 11.12.2018 / 10:40 The issuer is solely responsible for the content of this announcement. Edison initiates coverage of ADL Bionatur Solutions forecasting an equity valuation of EUR 2.37 per share with an upside potential of 42% - Potential upside of more than 42% compared to MAB closing price of...

DGAP-News: ADL Bionatur Solutions / Key word(s): Contract Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand 10.12.2018 / 10:45 The issuer is solely responsible for the content of this announcement. Amyris and ADL Bionatur Solutions Expand Production Agreement to Meet Growing Demand EMERYVILLE, California, USA and León, Spain - December 10, 2018 .- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of pure, sustainable, fermentation-derived...

DGAP-News: ADL Bionatur Solutions / Key word(s): Alliance Fermentalg and ADL BioPharma announce a majormanufacturing alliance to produce Omega 3 food supplements 26.09.2018 / 08:00 The issuer is solely responsible for the content of this announcement. Fermentalg and ADL BioPharma announce a majormanufacturing alliance to produce Omega 3 food supplements Libourne, France, and Madrid, Spain - 26 September 2018 - Fermentalg (Euronext - FALG), a French market leader in microalgae for human nutrition...

DGAP-News: ADL Bionatur Solutions / Key word(s): Financing ADL Bionatur Solutions Raises EUR 12 million with Institutional Investors 30.07.2018 / 10:30 The issuer is solely responsible for the content of this announcement. ADL Bionatur Solutions Raises EUR 12 million with Institutional Investors Capital Raise Follows Successful Listing at the Spanish Mercado Alternativo Bursátil (MAB) through a Reverse Acquisition of Bionaturis by ADL Biopharma León, Spain, 30 July 2018: ADL Bionatur Solutions...

...